Reported Sep 10, 2025 · Ongoing

Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy

Boothwyn Pharmacy LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Boothwyn Pharmacy LLC · 221 Gale Ln · Kennett Square, PA · 19348

Is this the product you have?

  • Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
Lot codes and dates
    • 03202025@2
    • 03202025@3 and 03202025@4 BUD 07/18/2025
Amount recalled
648 vials

This recall covers 4 products

The agency filed one notice per product. You are reading one of them; the other 3 are below.

Where it was sold

  • Nationwide

Why it was recalled

Subpotent Drug

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Boothwyn Pharmacy LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Data as of Sep 19, 8:05 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.